About Macrogenics (MGNX)
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company dev... Read more
- USD14.54
- USD15.05
- USD14.49
- USD21.88
- 0.70%
- 59M
- 1.39M
- 911M
- 4.29
- 115.10%
Stock News
30 minutes ago
CECO Environmental Corp (CECO) Q1 2024 Earnings: Mixed Results Amidst Record Revenues
Yahoo
33 minutes ago
Dow Jones Futures Fall Ahead Of Fed Meeting; Tesla Slides On New Layoffs
Yahoo
37 minutes ago
Democrats and Corporate Insiders are Buying These 10 Stocks
Yahoo
38 minutes ago
Young Americans' wealth grew by nearly 50% over the last 4 years—it's not just from buying homes
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
